Danske Bank A/s »

Cellectar Biosciences shares owned by Danske Bank A/s

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2025-09-30 $11 2 5.50

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Netflix (NFLX)

View all positions for Danske Bank A/s

Top funds holding Cellectar Biosciences

Bleichroeder
Vanguard Group
Renaissance Technologies
Geode Capital Management
DRW Holdings
Citadel Advisors
Dimensional Fund Advisors
Sequoia Financial Advisors
Riverview Capital Advisers
BlackRock
Tower Research Capital
UBS Group
Morgan Stanley
Group One Trading
Advisor Group Holdings

View all funds holding Cellectar Biosciences